A multi-team system implementation strategy to improve buprenorphine adherence for patients who initiate treatment in the emergency department
多团队系统实施策略,以提高在急诊科开始治疗的患者的丁丙诺啡依从性
基本信息
- 批准号:10740793
- 负责人:
- 金额:$ 100.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAccident and Emergency departmentAddressAdministratorAdoptionAffectAlcoholsBuprenorphineCaliforniaCaringClinicalClinical TrialsComplexConsolidated Framework for Implementation ResearchDataData CollectionDrug AddictionDrug usageElementsEmergency CareEmergency department visitFrequenciesFundingGoalsHealth systemHospitalsHybridsIndividualInsuranceInterviewKnowledgeLeadershipLegal patentLow incomeMaintenanceMedicaidMissionModelingOutpatientsOverdose reductionPatient CarePatient-Focused OutcomesPatientsPeripheralPharmaceutical PreparationsPhasePrimary CareProfessional counselorProtocols documentationPublic HealthRandomizedScienceSiteSurveysSystemSystems TheoryTestingTreatment outcomeUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthWorkaddictionbridge programbuprenorphine treatmentcandidate identificationcare coordinationcare fragmentationcare seekingcompliance behaviordesigneffective therapyeffectiveness measureeffectiveness outcomeeffectiveness/implementation studyimplementation measuresimplementation outcomesimplementation researchimplementation scienceimplementation strategyimplementation studyimprovedinnovationlensmembernovelopioid mortalityopioid overdoseopioid use disorderoverdose deathpatient populationpatient safetypost implementationprescription monitoring programprimary care clinicprimary care patientprimary care teamprimary care visitprogramsprospectiveretention rate
项目摘要
PROJECT SUMMARY/ABSTRACT
Drug overdose deaths continue to rise in the US due largely to opioid-related deaths, despite availability of
buprenorphine, a highly effective treatment for opioid use disorder (OUD). Starting buprenorphine for OUD in
emergency departments is an increasingly common practice across the US. A large clinical trial found that
emergency department-initiated buprenorphine plus referral to primary care for ongoing treatment significantly
increased buprenorphine treatment rates, but effects were not sustained past two months. Effective strategies
to help patients start, restart, and sustain buprenorphine treatment are urgently needed to reduce overdose
deaths. To increase buprenorphine treatment, California established CA Bridge, a state-funded program in
>200 hospitals that offers same-day buprenorphine initiation plus referral to primary care for patients with OUD
who seek care in emergency departments. However, suboptimal care coordination persists, especially for low-
income patients. This study’s overarching hypothesis is that an implementation strategy that encourages
coordination involving ongoing partnerships rather than one-time handoffs between emergency department
and primary care teams will improve buprenorphine treatment and retention rates for patients who start
buprenorphine in the emergency department. The objective is to refine an implementation strategy informed by
multiteam systems theory that is focused on improving OUD care coordination between emergency
department and primary care teams and then test this strategy in a hybrid type III effectiveness-implementation
study using a stepped wedge design randomized at the site level. The R61 phase will involve collecting and
analyzing data from two CA Bridge sites to identify core and peripheral elements of this implementation
strategy and develop an implementation strategy, a preliminary implementation blueprint, and data collection
protocols for the R33 phase. The stepped wedge study during the R33 phase will involve four CA Bridge sites.
Implementation outcomes will include between-team coordinating activities and care transitions. Effectiveness
outcomes will include rates of outpatient buprenorphine initiation (filling ≥1 outpatient prescription) and
sustained buprenorphine treatment 3, 6, and 12 months after patients leave the emergency department,
assessed with data from California’s prescription drug monitoring program. Factors associated with successful
implementation and sustainability will be identified through pre- and post-implementation interviews with
patients, staff, and managers at each emergency department and primary care clinic and through engagement
with relevant stakeholders, including patients, CA Bridge statewide leadership and prospective payers. Study
results will be used to develop an implementation blueprint that hospitals in California and across the US can
use to improve OUD treatment outcomes for patients who start buprenorphine in emergency departments. This
study will advance efforts to improve long-term buprenorphine treatment rates at scale for low-income and
other vulnerable patients who disproportionately seek OUD care in emergency departments.
项目总结/摘要
在美国,药物过量死亡人数继续上升,主要是由于阿片类药物相关的死亡,尽管有
丁丙诺啡,阿片类药物使用障碍(OUD)的高效治疗。开始使用丁丙诺啡治疗OUD,
急诊室是一个越来越普遍的做法在美国。一项大型临床试验发现,
急诊科启动的丁丙诺啡加转诊到初级保健进行持续治疗,
丁丙诺啡治疗率增加,但效果在过去两个月内没有持续。有效战略
帮助患者开始,重新开始和维持丁丙诺啡治疗,以减少过量
死亡为了增加丁丙诺啡的治疗,加州建立了加州桥,这是一个由州政府资助的项目,
>200家医院为OUD患者提供当天丁丙诺啡启动加初级保健转诊
在急诊室寻求治疗。然而,次优护理协调仍然存在,特别是对于低-
收入患者。这项研究的首要假设是,一个实施战略,鼓励
急诊科之间的协调涉及持续的伙伴关系,而不是一次性的合作
初级保健团队将改善丁丙诺啡治疗和保留率的患者谁开始
丁丙诺啡在急诊室目标是完善一项执行战略,
多团队系统理论,重点是改善OUD护理之间的紧急协调
部门和初级保健团队,然后在混合III型有效性实施中测试此策略
研究采用在研究中心水平随机化的阶梯式楔形设计。R61阶段将涉及收集和
分析来自两个CA Bridge站点的数据,以确定此实施的核心和外围元素
战略,并制定实施战略、初步实施蓝图和数据收集
R33阶段的协议。R33阶段的阶梯楔研究将涉及四个CA桥站点。
实施成果将包括团队之间的协调活动和护理过渡。有效性
结局将包括门诊丁丙诺啡启动率(填写≥1份门诊处方)和
患者离开急诊科后持续丁丙诺啡治疗3、6和12个月,
用来自加州处方药监测项目的数据进行评估。与成功相关的因素
实施和可持续性将通过实施前和实施后的访谈来确定,
每个急诊科和初级保健诊所的患者、工作人员和管理人员,
与相关利益相关者,包括患者,CA Bridge全州领导层和潜在付款人。研究
结果将用于制定实施蓝图,加州和美国各地的医院可以
用于改善在急诊室开始使用丁丙诺啡的患者的OUD治疗结果。这
研究将推动努力提高低收入人群的长期丁丙诺啡治疗率,
其他脆弱的病人谁不成比例地寻求OUD护理在急诊科。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen G Henry其他文献
Stephen G Henry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen G Henry', 18)}}的其他基金
Developing Patient-level Risk Prediction Models for Prescription Opioid Overdose
开发处方阿片类药物过量的患者级风险预测模型
- 批准号:
9982285 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
Developing Patient-level Risk Prediction Models for Prescription Opioid Overdose
开发处方阿片类药物过量的患者级风险预测模型
- 批准号:
9364793 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
A clinician training intervention to improve pain-related communication, pain management and opioid prescribing in primary care
临床医生培训干预,以改善初级保健中与疼痛相关的沟通、疼痛管理和阿片类药物处方
- 批准号:
9223594 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
Harnessing patient narratives to promote opioid tapering in primary care
利用患者的叙述来促进初级保健中阿片类药物的逐渐减少
- 批准号:
9304166 - 财政年份:2016
- 资助金额:
$ 100.52万 - 项目类别:
Harnessing patient narratives to promote opioid tapering in primary care
利用患者的叙述来促进初级保健中阿片类药物的逐渐减少
- 批准号:
9166045 - 财政年份:2016
- 资助金额:
$ 100.52万 - 项目类别: